First Bank & Trust’s Pfizer PFE Stock Holding History

First Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.4M	Buy	265,755 +8,373	+3%	+$219K	0.94%	16
2026 Q1	$7.23M	Buy	257,382 +73,242	+40%	+$1.95M	1.16%	15
2025 Q4	$4.59M	Buy	184,140 +32,523	+21%	+$820K	0.75%	24
2025 Q3	$3.86M	Buy	151,617 +80,401	+113%	+$1.98M	0.65%	34
2025 Q2	$1.73M	Buy	71,216 +1,738	+3%	+$40.5K	0.31%	70
2025 Q1	$1.76M	Buy	69,478 +3,063	+5%	+$80.2K	0.34%	65
2024 Q4	$1.76M	Sell	66,415 -11,280	-15%	-$306K	0.34%	62
2024 Q3	$2.25M	Buy	77,695 +2,459	+3%	+$71.7K	0.43%	54
2024 Q2	$2.11M	Buy	75,236 +3,451	+5%	+$95K	0.43%	54
2024 Q1	$1.99M	Buy	71,785 +29,342	+69%	+$814K	0.41%	58
2023 Q4	$1.22M	Sell	42,443 -18,386	-30%	-$556K	0.3%	76
2023 Q3	$2.02M	Sell	60,829 -453	-0.7%	-$16K	0.53%	46
2023 Q2	$2.25M	Buy	61,282 +10,471	+21%	+$408K	0.57%	42
2023 Q1	$2.07M	Buy	50,811 +9,231	+22%	+$399K	0.55%	39
2022 Q4	$2.13M	Buy	41,580 +3,245	+8%	+$156K	0.59%	37
2022 Q3	$1.68M	Buy	38,335 +1,470	+4%	+$71.4K	0.62%	45
2022 Q2	$1.93M	Sell	36,865 -367	-1%	-$18.7K	0.63%	37
2022 Q1	$1.93M	Sell	37,232 -1,158	-3%	-$60.1K	0.59%	38
2021 Q4	$2.27M	Sell	38,390 -31,949	-45%	-$1.58M	0.95%	26
2021 Q3	$3.02M	Sell	70,339 -2,965	-4%	-$131K	1.38%	12
2021 Q2	$2.87M	Buy	73,304 +6,963	+10%	+$271K	1.39%	13
2021 Q1	$2.4M	Buy	66,341 +4,935	+8%	+$175K	1.21%	19
2020 Q4	$2.26M	Sell	61,406 -3,559	-5%	-$131K	1.43%	13
2020 Q3	$2.26M	Buy	64,965 +1,468	+2%	+$51.5K	1.5%	12
2020 Q2	$1.97M	Sell	63,497 -12,540	-16%	-$426K	1.48%	14
2020 Q1	$2.35M	Buy	76,037 +21,112	+38%	+$719K	2.12%	7
2019 Q4	$2.04M	Buy	54,925 +11,366	+26%	+$405K	1.49%	16
2019 Q3	$1.49M	Buy	43,559 +39,429	+955%	+$1.43M	1.12%	25
2019 Q2	$170K	Sell	4,130 -3,404	-45%	-$135K	0.14%	142
2019 Q1	$304K	Sell	7,534 -1,223	-14%	-$49K	0.24%	106
2018 Q4	$363K	Sell	8,757 -11,238	-56%	-$467K	0.31%	90
2018 Q3	$788K	Buy	19,995 +19,045	+2,005%	+$733K	0.59%	61
2018 Q2	$33K	Buy	+950	New	+$32.5K	0.03%	214
2017 Q4	–	Sell	-91	Closed	-$3K	–	297
2017 Q3	$3K	Buy	+91	New	+$2.92K	﹤0.01%	236

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

First Bank & Trust's PFE Position: Q2 2026 in Review

First Bank & Trust increased its Pfizer (PFE) stake by 3.3% in Q2 2026, buying an estimated $219K and bringing the position to 265,755 shares worth $6.4M. The position accounts for 0.94% of the portfolio, ranked #16.

First Bank & Trust first reported a position in PFE in Q3 2017 and has held it in 34 quarters since. The position peaked at $7.23M in Q1 2026. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

First Bank & Trust held 265,755 shares of Pfizer worth $6.4M as of Q2 2026.
First Bank & Trust bought 8,373 Pfizer shares in Q2 2026, an estimated $219K.
Pfizer made up 0.94% of First Bank & Trust's portfolio in Q2 2026, its #16 holding.
First Bank & Trust first reported a position in Pfizer in Q3 2017 and has held it in 34 quarters since.
First Bank & Trust's Pfizer position peaked at $7.23M in Q1 2026.
557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.